Unequaled Expertise in Biologics
Rapid growth occurring in “new biotech” R&D
Unique products require efficacy and safety evaluation through different methods than those required by small molecules
- Route of exposure – intravenous, infusion, inhalation
- Species – Often requires primates
- Immunologic expertise - ELISA assay, pathology
Combined expertise is world class
- CRL-CTBR/Inveresk – world leaders in inhalation and infusion
- CRL-Sierra – scientific experts in NHP toxicology
- Unique regulatory consulting expertise in biologics
- Specialized pathology capabilities